Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 1111 AL 1125

The blood brain barrier in Alzheimer's disease

Chakraborty A, de Wit NM, van der Flier WM, de Vries HE.

Vascul Pharmacol. 2017 Feb;89:12-18. doi: 10.1016/j.vph.2016.11.008. Epub 2016 Nov 25.

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type

Garay RP, Grossberg GT.

Expert Opin Investig Drugs. 2017 Jan;26(1):121-132. doi: 10.1080/13543784.2017.1267726. Epub 2016 Dec 11.

Sleep disturbance: an emerging opportunity for Alzheimer's disease prevention?

Spira AP, Gottesman RF.

Int Psychogeriatr. 2017 Apr;29(4):529-531. doi: 10.1017/S1041610216002131. Epub 2016 Dec 12.

Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care

Bleckwenn M, Kleineidam L, Wagner M, Jessen F, Weyerer S, Werle J, Wiese B, Lühmann D, Posselt T, König HH, Brettschneider C, Mösch E, Weeg D, Fuchs A, Pentzek M, Luck T, Riedel-Heller SG, Maier W, Scherer M.

Br J Gen Pract. 2017 Feb;67(655):e111-e117. doi: 10.3399/bjgp16X688813. Epub 2016 Dec 19.

Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study

Guan Y, Roter DL, Erby LH, Wolff JL, Gitlin LN, Roberts JS, Green RC, Christensen KD.

Patient Educ Couns. 2017 May;100(5):927-935. doi: 10.1016/j.pec.2016.12.005. Epub 2016 Dec 14.

The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis

Moraros J, Nwankwo C, Patten SB, Mousseau DD.

Depress Anxiety. 2017 Mar;34(3):217-226. doi: 10.1002/da.22584. Epub 2016 Dec 28.

MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease

Regan B, Wells Y, Farrow M, O'Halloran P, Workman B.

Am J Geriatr Psychiatry. 2017 Mar;25(3):258-269. doi: 10.1016/j.jagp.2016.11.008. Epub 2016 Nov 16.

An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's disease

Zhang J, Chen C, Hua S, Liao H, Wang M, Xiong Y, Cao F.

Diabetes Res Clin Pract. 2017 Feb;124:41-47. doi: 10.1016/j.diabres.2016.10.024. Epub 2016 Nov 9.

Association between malnutrition and hyperhomocysteine in Alzheimer's disease patients and diet intervention of betaine

Sun J, Wen S, Zhou J, Ding S.

J Clin Lab Anal. 2017 Sep;31(5):e22090. doi: 10.1002/jcla.22090. Epub 2016 Nov 7.

Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277)

Qin XY, Cao C, Cawley NX, Liu TT, Yuan J, Loh YP, Cheng Y.

Mol Psychiatry. 2017 Feb;22(2):312-320. doi: 10.1038/mp.2016.62. Epub 2016 Apr 26.

PET biomarkers: Use of imaging techniques in Alzheimer disease and neurodegeneration clinical diagnosis

García-Ribas G, Arbizu J, Carrió I, Garrastachu P, Martinez-Lage P.

Neurologia. 2017 Jun;32(5):275-277. doi: 10.1016/j.nrl.2016.03.002. Epub 2016 May 5.

CSF Aβ(1-42) - an excellent but complicated Alzheimer's biomarker - a route to standardisation

Kuhlmann J, Andreasson U, Pannee J, Bjerke M, Portelius E, Leinenbach A, Bittner T, Korecka M, Jenkins RG, Vanderstichele H, Stoops E, Lewczuk P, Shaw LM, Zegers I, Schimmel H, Zetterberg H, Blennow K; IFCC Working Group on Standardization of CSF proteins (WG-CSF).

Clin Chim Acta. 2017 Apr;467:27-33. doi: 10.1016/j.cca.2016.05.014. Epub 2016 May 20.

Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease

Lista S, Hampel H.

Expert Rev Neurother. 2017 Jan;17(1):47-57. doi: 10.1080/14737175.2016.1204234. Epub 2016 Jul 1.

Plasma amyloid beta peptides: an Alzheimer's conundrum or a more accessible Alzheimer's biomarker?

Poljak A, Sachdev PS.

Expert Rev Neurother. 2017 Jan;17(1):3-5. doi: 10.1080/14737175.2016.1217156. Epub 2016 Jul 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias